Health Matters for Women - July 2024

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]



July 2024

Featured Story

CDC Office of Women's Health Commemorates 30 Years!


In recognition of CDC’s Office of Women’s Health (OWH) 30th anniversary, OWH is hosting a webinar titled, Women’s and Girls’ Health: Across Identities, Places, and Life Stages, on August 14, 2024, from 10:00am – 12:30pm EDT. Join this event and share it with your colleagues!

New from CDC Authors


CDC Prioritizes HIV Prevention and Treatment to Reduce HIV Disparities Among Cis-Gender Black Women

To succeed in ending the HIV epidemic in the United States, CDC focuses on delivering combinations of scientifically proven, cost-effective, and scalable interventions to priority populations.


Bilateral Oophorectomy Prevalence Among U.S. Women

Bilateral oophorectomy has been linked to poor health outcomes, some of which can have a long latency period. Limited data are available on bilateral oophorectomy prevalence among U.S. women.


Sexual and Reproductive Health Among Cisgender Women With HIV Aged 18-44 Years

The sexual and reproductive health of cisgender women with HIV is essential for their overall health and well-being. Nationally representative estimates of sexual and reproductive health outcomes among women with HIV were assessed in this study.


Claims for Contraceptive Services and Chlamydia and Gonorrhea Testing Among Insured Adolescent and Young Adult Females in the United States

This report examines claims for reversible prescription contraceptives and chlamydia and gonorrhea testing among commercially and Medicaid-insured adolescent and young adult (AYA) females in the United States. 


WHO Antenatal Care Policy and Prevention of Malaria in Pregnancy in sub-Saharan Africa

This study assessed antenatal care (ANC) uptake following policy implementation and explored the relationship between ANC attendance and intermittent preventive treatment in pregnancy (IPTp) coverage in sub-Saharan Africa following the rollout of the WHO 2016 ANC policy, specifically, to assess differences in IPTp uptake between women attending eight versus four ANC contacts.


Progress Toward Achieving and Sustaining Maternal and Neonatal Tetanus Elimination — Worldwide, 2000–2022

Tetanus causes considerable mortality among undervaccinated mothers and their infants following unhygienic deliveries, especially in low-income countries. The maternal and neonatal tetanus elimination initiative targets 59 priority countries.


A Study on Economic Stressors During the COVID-19 Pandemic Among Intimate Partner and Sexual Violence Survivors in the United States

Public health emergencies compound vulnerabilities for survivors of intimate partner violence and sexual violence and those who self-identify as people from racial and ethnic minority groups.


Prevented Perinatal HIV Infections in the Era of Antiretroviral Prophylaxis and Treatment, United States, 1994-2020

The primary aim of this serial cross-sectional analysis is to estimate the total number of prevented perinatal HIV transmissions from the time of the initial recommendation for perinatal zidovudine prophylaxis in 1994 through 2020 in the US. 


Building Capacity of Community Health Centers to Improve the Provision of Postpartum Care Services Through Data-Driven Health Information Technology and Innovation

Maternal morbidity and mortality remain significant challenges in the United States, with substantial burden during the postpartum period. CDC in partnership with the National Association of Community Health Centers, began an initiative to build capacity in Federally Qualified Health Centers to improve the infrastructure for perinatal care measures and use perinatal care measures to identify and address gaps in postpartum care.


Birth Outcomes Related to Prenatal Zika, Dengue, and Other Flavivirus Infections in the Zika en Embarazadas y Niños Prospective Cohort Study in Colombia

Zika virus infection in pregnancy is associated with severe abnormalities of the brain and eye and other adverse outcomes.



Snapshots

What's Happening in Women's Health

Question of the Month

When should women get screened for group B Streptococcus (group B strep, GBS) bacteria?


A. During menopause

B. Every 5 years

C. During the 36 or 37 week of pregnancy

How did you do on last month's question?

What is the best known risk factor for Alzheimer’s disease? 


Congratulations! Most of you chose the correct answer, Age. Scientists do not yet fully understand what causes Alzheimer’s disease. There likely is not a single cause but rather several factors that can affect each person differently. Age is the best known risk factor for Alzheimer’s disease. Learn more about Alzhemiers disease and related dementias.


How did your answer compare? Thank you to all who responded! 

Health Observances

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  | 

This service is provided by the CDC/ATSDR Office of Women's Health. Email comments or suggestions to owh@xxxxxxx.

For more information about women’s health, visit www.cdc.gov/women.

Disclaimer:

The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Links to non-Federal organizations are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC/ATSDR or the Federal Government, and none should be inferred. The CDC/ATSDR is not responsible for the content of the individual organization Web pages found at these links.

If you're having trouble reading this message, click here


[Index of Archives]     [NIH News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [SB Lupus]     [STB]
  Powered by Linux